Trial Profile
Comparison of pharmacodynamic and pharmacokinetics of biosimilar rituximab (reditux) versus rituximab (mabthera) in patients with diffuse large B cell lymphoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jul 2017
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisolone; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Pharmacokinetics
- 08 Apr 2015 New trial record